Athersys gets FDA OK for phase 2/3 to study MultiStem in patients with COVID-19-induced ARDS

0
135



This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.





Source : MTV